CARRICK PHARMA LTD

Company Registration Number:
SC686674 (Scotland)

Unaudited abridged accounts for the year ended 31 March 2026

Period of accounts

Start date: 01 April 2025

End date: 31 March 2026

CARRICK PHARMA LTD

Contents of the Financial Statements

for the Period Ended 31 March 2026

Balance sheet
Notes

CARRICK PHARMA LTD

Balance sheet

As at 31 March 2026


Notes
2026
2025


£
£
Fixed assets
Intangible assets: 3 1,346,044 1,427,312
Tangible assets: 4 143,081 77,707
Total fixed assets: 1,489,125 1,505,019
Current assets
Stocks: 31,158 36,045
Debtors:   323,502 255,103
Cash at bank and in hand: 357,450 90,283
Total current assets: 712,110 381,431
Creditors: amounts falling due within one year:   (633,203) (501,248)
Net current assets (liabilities): 78,907 (119,817)
Total assets less current liabilities: 1,568,032 1,385,202
Creditors: amounts falling due after more than one year:   (1,393,764) (1,269,288)
Total net assets (liabilities): 174,268 115,914
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 174,168 115,814
Shareholders funds: 174,268 115,914

The notes form part of these financial statements

CARRICK PHARMA LTD

Balance sheet statements

For the year ending 31 March 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 01 July 2026
and signed on behalf of the board by:

Name: Jane Shennan
Status: Director

The notes form part of these financial statements

CARRICK PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2026

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

CARRICK PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2026

2. Employees

2026 2025
Average number of employees during the period 23 19

CARRICK PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2026

3. Intangible Assets

Total
Cost £
At 01 April 2025 1,625,597
At 31 March 2026 1,625,597
Amortisation
At 01 April 2025 198,285
Charge for year 81,268
At 31 March 2026 279,553
Net book value
At 31 March 2026 1,346,044
At 31 March 2025 1,427,312

CARRICK PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2026

4. Tangible Assets

Total
Cost £
At 01 April 2025 93,976
Additions 72,838
At 31 March 2026 166,814
Depreciation
At 01 April 2025 16,269
Charge for year 7,464
At 31 March 2026 23,733
Net book value
At 31 March 2026 143,081
At 31 March 2025 77,707